🟢 UroGen Pharma is trading 4.25% up today amid broad market risk-on sentiment

UroGen Pharma is trading 4.25% up at $49.11, alongside a broader risk-on session.

• The Nasdaq Composite is up 0.66%, while the S&P 500 is up 0.33%.
• No new company-specific announcement dated August 12, 2026 was identified.
• Investor sentiment may still be supported by the August 5 earnings report, which showed $72.5 million in quarterly revenue and $50.4 million from ZUSDURI, but it does not directly explain today’s move.